Your Messages Inbox
Your Article Summary
See Latest ArticlesAvigens Board of Directors to Review BVF Offer and Provide Recommendation
Avigen, 04/02/09
Avigen, Inc. , a biopharmaceutical company, confirmed that BVF Acquisition LLC, a wholly owned subsidiary of Biotechnology Value Fund, L.P. , had commenced an unsolicited tender offer to purchase all of the outstanding shares of Avigen's common stock that BVF does not already own for $1.00 per share in cash.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09
Article Search
Sponsor